Proctor & Gamble is seeking a technology solution to manage the e2e Creative Content Supply chain.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Christina Qi, Partner, Domeyard LP
Dilip Sundaram - Corporate Keynote
Exploring opportunities in healthcare and related applications by leveraging cutting edge technologies
The MIT Bangkok Symposium is the first regional conference in Thailand organized by the MIT Industrial Liaison Program (ILP), in cooperation with Bangkok Bank, Ltd. The symposium will bring together industry, academic, and investment leaders from the Healthcare and BioTech ecosystem at MIT and across Southeast Asia to Bangkok, Thailand. Attendees will benefit from distinguished speakers and panelists, including industry luminaries, pioneers, investors, and world-class researchers, with whom they can interact during networking sessions. HealthTech and BioTech entrepreneurs from the MIT Startup Exchange will exhibit their transformative solutions in the Symposium and be open to discuss potential collaboration with attendees.
Get ready for the MIT $100K Launch Competition, where entrepreneurs battle it out for a chance to win big money and advance their startup.
Does your startup have a solution for urgent Covid-19 needs? Ideally they should be validated to work and demonstrate feasibility to scale. And could contacts to corporates help you scale up? MIT Startup Exchange is looking to help you connect.